Back to search

Article

Synergic Role of Dexamethasone And Lianhua Qingwen Capsule Accelerate Nucleic Acid Negative Conversion In Severe COVID-19 Patients

2021-10-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold>Corticosteroids were recommended by guidelines in severe or critical COVID -19 patients likely to have acute respiratory distress syndrome. In the treatment strategies of COVID -19 in China, corticosteroids were generally combined with some traditional Chinese medicine, especially Lianhua Qingwen Capsule (LHQW). We aimed to investigate the correlation between dex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
79fc2a41-9af9-5b3a-9b1e-d108623de76b
DOI
10.21203/rs.3.rs-955194/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synergic Role of Dexamethasone And Lianhua Qingwen Capsule Accelerate Nucleic Acid Negative Conversion In Severe COVID-19 PatientsDOI 10.21203/rs.3.rs-955194/v1
Analysis of Factors Affecting the Nucleic Acid Negative Conversion Time after SARS-CoV-2 Omicron Variant InfectionSemantic proximity
Chinese Guidelines Related to Novel Coronavirus PneumoniaSemantic proximity
Delayed discharge is associated with higher complement C3 levels and a longer nucleic acid-negative conversion time in patients with COVID-19Semantic proximity
A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19Semantic proximity
Clinical Symptom Influence on The Time of Nucleic Acid Conversion to Negative in COVID-19 Patients with SARS-CoV-2 Omicron Variant: A Retrospective Observational StudySemantic proximity
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection.Semantic proximity
Effects of (Combined) Chinese Medicine on the Risk of Death From COVID-19: A Retrospective Data Analysis Based on 4567 PatientsSemantic proximity
Efficacy and safety of convalescent plasma therapy for severe COVID-19 patients：case series study and literature reviewSemantic proximity
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic dataSemantic proximity
Dexamethasone Ameliorates Severe Pneumonia But Slightly Enhances Viral Replication in Lung of SARS-CoV-2-Infected Syrian HamsterSemantic proximity
Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19Semantic proximity
‘Which severe COVID-19 patients could benefit from High dose dexamethasone? A Bayesian reanalysis of a randomized clinical trialSemantic proximity
Select a neighboring publication to make it the new centre.